CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Pharma’s Boonton, NJ site received DEA Schedule II-III registration, expanding integrated development and clinical supply services for OINDPs.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.